Cargando…
Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study
Objective: This study aimed to assess the association between treatment characteristics of prostaglandin E1 including initiation time and duration, maximal and cumulative doses, and adverse effects. Design: A retrospective cohort study in which medical records of neonates with duct-dependent lesions...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528554/ https://www.ncbi.nlm.nih.gov/pubmed/37761532 http://dx.doi.org/10.3390/children10091572 |
_version_ | 1785111276400148480 |
---|---|
author | Ofek Shlomai, Noa Lazarovitz, Gilad Koplewitz, Benjamin Eventov Friedman, Smadar |
author_facet | Ofek Shlomai, Noa Lazarovitz, Gilad Koplewitz, Benjamin Eventov Friedman, Smadar |
author_sort | Ofek Shlomai, Noa |
collection | PubMed |
description | Objective: This study aimed to assess the association between treatment characteristics of prostaglandin E1 including initiation time and duration, maximal and cumulative doses, and adverse effects. Design: A retrospective cohort study in which medical records of neonates with duct-dependent lesions were studied for treatment parameters and adverse effects. Multivariable logistic regression model was applied for testing the effect PGE1 variables on outcomes. Main outcome measures: The primary outcomes of this study were association of adverse effects of PGE1 treatment with maximal dose, cumulative dose, and treatment duration. The secondary outcomes included safety of feeding in infants treated with PGE1. Results: Eighty-two infants with duct-dependent lesions receiving PGE1 were included. Several infants who received early PGE1 treatment required ventilation support. Feeds were ceased more often as the cumulative dose and duration of PGE1 treatment increased. Gastrointestinal adverse effects were significantly associated with the cumulative dose of PGE1 and treatment duration. Apneas, hyperthermia, and tachycardia were associated with maximal dose. Our data did not demonstrate a difference in the incidence of NEC associated with characteristics of PGE1 treatment. Conclusion: Cumulative PGE1 dose is associated with gastrointestinal adverse effects in neonates. Lower doses should be considered in neonates expecting prolonged PGE1 treatment. |
format | Online Article Text |
id | pubmed-10528554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105285542023-09-28 Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study Ofek Shlomai, Noa Lazarovitz, Gilad Koplewitz, Benjamin Eventov Friedman, Smadar Children (Basel) Article Objective: This study aimed to assess the association between treatment characteristics of prostaglandin E1 including initiation time and duration, maximal and cumulative doses, and adverse effects. Design: A retrospective cohort study in which medical records of neonates with duct-dependent lesions were studied for treatment parameters and adverse effects. Multivariable logistic regression model was applied for testing the effect PGE1 variables on outcomes. Main outcome measures: The primary outcomes of this study were association of adverse effects of PGE1 treatment with maximal dose, cumulative dose, and treatment duration. The secondary outcomes included safety of feeding in infants treated with PGE1. Results: Eighty-two infants with duct-dependent lesions receiving PGE1 were included. Several infants who received early PGE1 treatment required ventilation support. Feeds were ceased more often as the cumulative dose and duration of PGE1 treatment increased. Gastrointestinal adverse effects were significantly associated with the cumulative dose of PGE1 and treatment duration. Apneas, hyperthermia, and tachycardia were associated with maximal dose. Our data did not demonstrate a difference in the incidence of NEC associated with characteristics of PGE1 treatment. Conclusion: Cumulative PGE1 dose is associated with gastrointestinal adverse effects in neonates. Lower doses should be considered in neonates expecting prolonged PGE1 treatment. MDPI 2023-09-19 /pmc/articles/PMC10528554/ /pubmed/37761532 http://dx.doi.org/10.3390/children10091572 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ofek Shlomai, Noa Lazarovitz, Gilad Koplewitz, Benjamin Eventov Friedman, Smadar Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title | Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title_full | Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title_fullStr | Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title_full_unstemmed | Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title_short | Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study |
title_sort | cumulative dose of prostaglandin e1 determines gastrointestinal adverse effects in term and near-term neonates awaiting cardiac surgery: a retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528554/ https://www.ncbi.nlm.nih.gov/pubmed/37761532 http://dx.doi.org/10.3390/children10091572 |
work_keys_str_mv | AT ofekshlomainoa cumulativedoseofprostaglandine1determinesgastrointestinaladverseeffectsintermandneartermneonatesawaitingcardiacsurgeryaretrospectivecohortstudy AT lazarovitzgilad cumulativedoseofprostaglandine1determinesgastrointestinaladverseeffectsintermandneartermneonatesawaitingcardiacsurgeryaretrospectivecohortstudy AT koplewitzbenjamin cumulativedoseofprostaglandine1determinesgastrointestinaladverseeffectsintermandneartermneonatesawaitingcardiacsurgeryaretrospectivecohortstudy AT eventovfriedmansmadar cumulativedoseofprostaglandine1determinesgastrointestinaladverseeffectsintermandneartermneonatesawaitingcardiacsurgeryaretrospectivecohortstudy |